XXVII EFMC International Symposium on Medicinal Chemistry

 Nice, France    September 4-8, 2022

Session Topics

The parallel sessions are grouped in 3 different themes:

  1. Chemical Biology
  2. Drug Discovery Projects
  3. Technologies

In addition, the programme contains three open sessions: First Time Disclosures (I & II) and Recent Highlights in Medicinal Chemistry. For these sessions, the talks will be selected from the submitted abstracts.

For most of the below topics, a slot in the programme will be available for an oral communication selected out of the submitted abstracts.

Chemical Biology

  • Addressing Cooperative Ligand Binding in Drug Discovery (EUCHEMS Session)
    Chair: Prof. Luc Brunsveld, Eindhoven University of Technology, NL

  • Targeting Self-Associating Proteins & Biomolecular Condensates in Drug Discovery
    Chair: Prof. Raphaël Frederick, UCLouvain, BE

  • Beyond PROTACS, Monovalent and Glues Degraders
    Chair: Dr Laura M. Luh, Bayer, DE

  • Targeting Epigenetic Modifications in Cancer Therapy (ICBS Session)
    Chair: Prof. Zaneta Nikolovska-Coleska, University of Michigan, US

  • Chemical Probes for Target Identification & Validation
    Chair: Dr Joanna Redmond, GlaxoSmithKline, UK
  • In vivo Chemistry to Study Biological Mechanisms and to Develop Innovative Tools for Therapy and Diagnosis
    Chair: Dr Frédéric Taran, CEA/Saclay, FR

  • Mining the Phosphosignaling Networks
    Chair: Dr Nadia Ahmad, Charles River, UK

Drug Discovery Projects

  • Drug Discovery in Targeting Neurodegenerative Disorders (ACS Session)
    Chair: Dr Rong Huang, Purdue University, US

  • Covalent Drugs
    Chair: Dr Samir Jegham, Sanofi, FR

  • Rising Horizons of Small Molecule Immunotherapies and Beyond
    Chair: Prof. Antonio Macchiarulo, University of Perugia, IT

  • New Treatments for Current and Future Pandemics
    Chair: Prof. Ana Martinez, CSIC, ES

  • Time to Act Against Antimicrobial Resistance
    Chair: Prof. Maria-Jesus Pérez-Pérez, Instituto de Química Médica, ES

  • Targeting RNA by Small Molecules
    Chair: Dr Hasane Ratni, F. Hoffmann-La Roche, CH

  • Drugging the Undruggable: Targeting Transcription Factors (ACS Session)
    Chair: Dr Anthony Romero, Oric Pharmaceuticals, US

  • Renaissance of Natural-Product Inspired Drug Discovery in the 21st Century
    Chair: Dr Boris Vauzeilles, Institut de Chimie des Substances Naturelles, FR


  • Bioanalytics for DD: New Developments and Applications of Affinity Selection – Mass Spectrometry
    Chair: Dr Didier Roche, Edelris, FR

  • Innovative Synthetic Technologies for Drug Discovery
    Chair: Dr Cara Brocklehurst, Novartis, CH

  • Hit Discovery with DNA-Encoded Libraries
    Chair: Dr Andreas Brunschweiger, TU Dortmund, DE

  • AI in Drug Discovery (CPA Session)
    Chair: Dr Jiang Hualiang, Shanghai Institute of Materia Medica, CN

  • Methods for Late-Stage Functionalization
    Chair: Prof. Tobias Ritter, MPI für Kohlenforschung, DE

  • Gut Specific Targeting Strategies of Drug Candidates
    Chair: Dr Jan Willem Thuring, Janssen, BE

  • Radiochemistry (AFMC Session)
    Chair: Prof. Sun Choi, Division of Medicinal Chemistry of Pharmaceutical Society, KR

  • Next Generation Medicinal Chemistry – An EFMC2 Session
    Chair: Dr Clara Christ, Bayer, DE

Open Sessions (selected from submitted abstracts)

  • First Time Disclosures (I & II)
    Session Chairs to be announced

  • Recent Highlights in Medicinal Chemistry
    Session Chair to be announced